These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34608628)

  • 61. Levetiracetam monotherapy in children with epilepsy: Experience from a tertiary pediatric neurology center.
    Yıldırım M; Bektaş Ö; Akıncı Göktaş Ö; Yüksel MF; Şahin S; Tıraş Teber S
    Epilepsy Behav; 2021 Mar; 116():107745. PubMed ID: 33508749
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Tolerability, safety, and efficacy of adjunctive brivaracetam for focal seizures in older patients: A pooled analysis from three phase III studies.
    Brodie MJ; Whitesides J; Schiemann J; D'Souza J; Johnson ME
    Epilepsy Res; 2016 Nov; 127():114-118. PubMed ID: 27589414
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clinical experience with brivaracetam in a series of 46 children.
    Visa-Reñé N; Raspall-Chaure M; Paredes-Carmona F; Coromina JS; Macaya-Ruiz A
    Epilepsy Behav; 2020 Jun; 107():107067. PubMed ID: 32302941
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Adjunctive Brivaracetam in Indian Patients with Uncontrolled Focal Epilepsy: Results from a Pooled Analysis of Two Double-Blind, Randomized, Placebo-Controlled Trials.
    Srinivasa R; Sinha S; Parthasarthy S; Kothari S; Baviskar R; Jayalakshmi S; Sharma B; Garg RK; Desai J; Yardi N; Salvadeeswaran MS; Ravat S; Das M; Gursahani R; Suresh S; Rasal A; Elmoufti S
    Neurol India; 2020; 68(6):1400-1408. PubMed ID: 33342876
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Safety and tolerability of adjunctive brivaracetam in children with focal seizures: Interim analysis of pooled data from two open-label trials.
    Patel AD; Badalamenti V; Gasalla T; Elmoufti S; Elshoff JP
    Eur J Paediatr Neurol; 2020 Mar; 25():68-76. PubMed ID: 31810577
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Retention rate of levetiracetam in children with intractable epilepsy at 1 year.
    Peake D; Mordekar S; Gosalakkal J; Mukhtyar B; Buch S; Crane J; Wheway R; Rittey C; Donnelly J; Whitehouse WP; Philip S
    Seizure; 2007 Mar; 16(2):185-9. PubMed ID: 17258474
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Adjunctive brivaracetam for patients with refractory partial seizures: A meta-analysis of randomized placebo-controlled trials.
    Ma J; Huang S; You C
    Epilepsy Res; 2015 Aug; 114():59-65. PubMed ID: 26088886
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures.
    Mumoli L; Palleria C; Gasparini S; Citraro R; Labate A; Ferlazzo E; Gambardella A; De Sarro G; Russo E
    Drug Des Devel Ther; 2015; 9():5719-25. PubMed ID: 26543353
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Brivaracetam add-on for refractory focal epilepsy: A systematic review and meta-analysis.
    Lattanzi S; Cagnetti C; Foschi N; Provinciali L; Silvestrini M
    Neurology; 2016 Apr; 86(14):1344-1352. PubMed ID: 26944275
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Brivaracetam as Early Add-On Treatment in Patients with Focal Seizures: A Retrospective, Multicenter, Real-World Study.
    Lattanzi S; Canafoglia L; Canevini MP; Casciato S; Cerulli Irelli E; Chiesa V; Dainese F; De Maria G; Didato G; Di Gennaro G; Falcicchio G; Fanella M; Ferlazzo E; Gangitano M; La Neve A; Mecarelli O; Montalenti E; Morano A; Piazza F; Pizzanelli C; Pulitano P; Ranzato F; Rosati E; Tassi L; Di Bonaventura C;
    Neurol Ther; 2022 Dec; 11(4):1789-1804. PubMed ID: 36109431
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Brivaracetam in the treatment of patients with epilepsy].
    Karlov VA; Vlasov PN; Zhidkova IA; Kissin MY; Lebedeva AV; Lipatova LV; Mkrtchyan VR; Mukhin KY; Rudakova IG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(9. Vyp. 2):55-62. PubMed ID: 29213040
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Brivaracetam for the treatment of epilepsy.
    Schulze-Bonhage A
    Expert Opin Pharmacother; 2011 Aug; 12(12):1959-66. PubMed ID: 21682662
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Neurocognitive effects of brivaracetam, levetiracetam, and lorazepam.
    Meador KJ; Gevins A; Leese PT; Otoul C; Loring DW
    Epilepsia; 2011 Feb; 52(2):264-72. PubMed ID: 20887370
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Brivaracetam augments short-term depression and slows vesicle recycling.
    Yang X; Bognar J; He T; Mohammed M; Niespodziany I; Wolff C; Esguerra M; Rothman SM; Dubinsky JM
    Epilepsia; 2015 Dec; 56(12):1899-909. PubMed ID: 26515103
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Efficacy and tolerability of levetiracetam during 1-year follow-up in patients with refractory epilepsy.
    Ben-Menachem E; Gilland E
    Seizure; 2003 Apr; 12(3):131-5. PubMed ID: 12651076
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Brivaracetam: First Canadian Experience in an Intractable Epilepsy Population.
    Lafortune J; Deacon C; Clément JF
    Can J Neurol Sci; 2020 Mar; 47(2):183-188. PubMed ID: 31685045
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Rapid intravenous loading of brivaracetam during invasive and non-invasive video-EEG monitoring.
    Chavarría B; Zucca R; Principe A; Sanabria A; Rocamora R
    Epilepsy Res; 2023 May; 192():107145. PubMed ID: 37087911
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Brivaracetam in Unverricht-Lundborg disease (EPM1): Results from two randomized, double-blind, placebo-controlled studies.
    Kälviäinen R; Genton P; Andermann E; Andermann F; Magaudda A; Frucht SJ; Schlit AF; Gerard D; de la Loge C; von Rosenstiel P
    Epilepsia; 2016 Feb; 57(2):210-21. PubMed ID: 26666500
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Evidence for sustained efficacy of levetiracetam as add-on epilepsy therapy.
    Ben-Menachem E; Edrich P; Van Vleymen B; Sander JW; Schmidt B
    Epilepsy Res; 2003 Feb; 53(1-2):57-64. PubMed ID: 12576168
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Treatment of refractory and super-refractory status epilepticus with brivaracetam: A cohort study from two German university hospitals.
    Strzelczyk A; Steinig I; Willems LM; Reif PS; Senft C; Voss M; Gaida B; von Podewils F; Rosenow F
    Epilepsy Behav; 2017 May; 70(Pt A):177-181. PubMed ID: 28427029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.